Neonatal Modulation of Airway Contractility

Project: Research project

Project Details


ABSTRACT Supplemental oxygen (hyperoxia) with/without continuous nasal positive airway pressure (CPAP) to preterm infants is associated with airway hyperreactivity (AHR) proceeding to wheezing and asthma. Understanding mechanisms by which hyperoxia and CPAP induce sustained AHR represents our long-term goal, and an unmet clinical need. We propose the initial stretch imposed by CPAP on more compliant bronchial airways in premature infants, particularly with added hyperoxia, is contributory. AHR involves greater [Ca2+]i and contractility of airway smooth muscle (ASM), and remodeling mediated partly by ASM proliferation. Our published studies and preliminary work using human fetal airway cells and neonatal mouse models show moderate hyperoxia (50% O2) and mechanical stretch not only enhance ASM contractility and proliferation, but also bronchial epithelial arginase, raising the question of whether and how epithelial arginase and neonatal AHR are linked. We propose the novel and intriguing idea that arginase-derived polyamines (e.g. spermine) have downstream effects on a novel ASM target: extracellular Ca2+ sensing receptor (CaSR). Although well-known for regulating body Ca2+, there is limited information on CaSR in lung, and none in postnatal airways. Preliminary data in developing human airways show high expression of ASM CaSR that responds to extracellular Ca2+ ([Ca2+]o) or spermine, and enhances [Ca2+]I, contractility and proliferation. Hyperoxia and stretch each increase CaSR expression and function. In neonatal mice exposed to 50% O2 and/or CPAP which show sustained AHR, epithelial arginase and ASM CaSR are increased, while inhibitors of arginase (nor-NOHA) and CaSR (calcilytic NPS2143) blunt AHR. Our overall hypothesis is that the epithelial arginase-ASM CaSR axis contributes to AHR in the context of hyperoxia and CPAP exposure in prematurity. We will examine this idea via 3 Aims. Aim 1: In developing bronchial epithelium, determine the effect of hyperoxia and/or stretch on the arginase pathway; Aim 2: In developing ASM, determine the role of CaSR in enhanced [Ca2+]i/contractility and proliferation induced by hyperoxia and/or stretch; Aim 3: In neonatal mouse models of hyperoxia and/or CPAP exposure, determine the role of the arginase-CaSR axis in AHR and airway remodeling. 18-22 week human fetal bronchial epithelial cells (fBECs) and ASM cells (fASM) are exposed to hyperoxia (
StatusNot started


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.